311 related articles for article (PubMed ID: 11883817)
1. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children.
Olafsdottir E; Aksnes L; Fluge G; Berstad A
Acta Paediatr; 2002; 91(1):45-50. PubMed ID: 11883817
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):171-7. PubMed ID: 11321388
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Gray ES; Olson S; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):14-22. PubMed ID: 11479402
[TBL] [Abstract][Full Text] [Related]
4. Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey.
Hestvik E; Tumwine JK; Tylleskar T; Grahnquist L; Ndeezi G; Kaddu-Mulindwa DH; Aksnes L; Olafsdottir E
BMC Pediatr; 2011 Feb; 11():9. PubMed ID: 21284894
[TBL] [Abstract][Full Text] [Related]
5. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
6. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease.
Røseth AG; Schmidt PN; Fagerhol MK
Scand J Gastroenterol; 1999 Jan; 34(1):50-4. PubMed ID: 10048733
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay.
Diamanti A; Panetta F; Basso MS; Forgione A; Colistro F; Bracci F; Papadatou B; Francalanci P; Torroni F; Knafelz D; Fina F; Castro M
Inflamm Bowel Dis; 2010 Nov; 16(11):1926-30. PubMed ID: 20310017
[TBL] [Abstract][Full Text] [Related]
8. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent variations in fecal calprotectin concentrations in children.
Rugtveit J; Fagerhol MK
J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):323-4; author reply 324-5. PubMed ID: 11964964
[No Abstract] [Full Text] [Related]
10. Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease.
Burri E; Beglinger C
Swiss Med Wkly; 2012; 142():w13557. PubMed ID: 22481443
[TBL] [Abstract][Full Text] [Related]
11. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
[TBL] [Abstract][Full Text] [Related]
12. Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.
Heida A; Van de Vijver E; van Ravenzwaaij D; Van Biervliet S; Hummel TZ; Yuksel Z; Gonera-de Jong G; Schulenberg R; Muller Kobold A; van Rheenen PF;
Arch Dis Child; 2018 Jun; 103(6):565-571. PubMed ID: 29514815
[TBL] [Abstract][Full Text] [Related]
13. Use of faecal immunochemical testing as an alternative to faecal calprotectin in children.
Sandhu K; Naik S; Ayling RM
Ann Clin Biochem; 2021 May; 58(3):230-235. PubMed ID: 33412889
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
Oyaert M; Trouvé C; Baert F; De Smet D; Langlois M; Vanpoucke H
Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
[TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin in children with chronic gastrointestinal symptoms.
Bremner A; Roked S; Robinson R; Phillips I; Beattie M
Acta Paediatr; 2005 Dec; 94(12):1855-8. PubMed ID: 16421055
[TBL] [Abstract][Full Text] [Related]
16. How to use faecal calprotectin in management of paediatric inflammatory bowel disease.
Saha A; Tighe MP; Batra A
Arch Dis Child Educ Pract Ed; 2016 Jun; 101(3):124-8. PubMed ID: 26848103
[TBL] [Abstract][Full Text] [Related]
17. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
[TBL] [Abstract][Full Text] [Related]
18. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
Summerton CB; Longlands MG; Wiener K; Shreeve DR
Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):841-5. PubMed ID: 12172403
[TBL] [Abstract][Full Text] [Related]
19. Role of faecal calprotectin as non-invasive marker of intestinal inflammation.
Costa F; Mumolo MG; Bellini M; Romano MR; Ceccarelli L; Arpe P; Sterpi C; Marchi S; Maltinti G
Dig Liver Dis; 2003 Sep; 35(9):642-7. PubMed ID: 14563186
[TBL] [Abstract][Full Text] [Related]
20. Paediatric reference ranges for faecal calprotectin: a UK study.
Davidson F; Lock RJ
Ann Clin Biochem; 2017 Mar; 54(2):214-218. PubMed ID: 27141011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]